Jornadal, Misonilyn .
HRN: 22-91-42 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/03/2023
CEFUROXIME 1.5GM (VIAL)
06/03/2023
06/06/2023
IV
1.5g
X 3 Doses
S/P CS
Waiting Final Action
Indication: Empiric Type of Infection: Intra-abdominal Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes